Preventive role of carvedilol in adriamycin-induced cardiomyopathy

BACKGROUND & OBJECTIVES: Adriamycin though considered as an effective anticancer drug, leads to irreversible cardiomyopathy (CMP) and congestive heart failure (CHF). The aim of this study was to determine the protective effect of carvedilol in adriamycin (ADR)-induced cardiomyopathy (CMP) in can...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Indian J Med Res
Main Authors: Jhorawat, Rajesh, Kumari, Savita, Varma, Subhash C., Rohit, Manoj K., Narula, Nidhi, Suri, Vikas, Malhotra, Pankaj, Jain, Sanjay
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2016
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5393084/
https://ncbi.nlm.nih.gov/pubmed/28361826
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/ijmr.IJMR_1323_14
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados